✦ LIBER ✦
PCN41 DRUG COST CONSIDERATIONS FOR ERYTHROPOIETIC STIMULATING THERAPIES (ESTS) AGENTS IN PATIENTS INITIATED AT FDA-APPROVED DOSING: RESULTS FROM PRACTICE PATTERNS IN A PROSPECTIVE OBSERVATIONAL STUDY
✍ Scribed by CL Pashos; Q Wang; K Larholt; B Bookhart; RS Mckenzie; CT Piech
- Book ID
- 118608514
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 70 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.